IP Library Patent Application 12114194
Patent Application
App. No. 12/114,194

APPARATUS AND METHODS FOR INJECTING HIGH VISCOSITY DERMAL FILLERS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/114,194
Abstract

A method includes inserting a distal end portion of a needle of a medical injector into a skin of a body. An energy source operatively coupled to the medical injector is actuated such that a dermal filler is conveyed from the medical injector into the skin through the distal end portion of the needle. The distal end portion of the needle is moved within the skin during the actuating.

Claims (77)

1 . A method, comprising

inserting a distal end portion of a needle of a medical injector into a skin of a body;

actuating an energy source operatively coupled to the medical injector such that a dermal filler is conveyed from the medical injector into the skin through the distal end portion of the needle; and

moving the distal end portion of the needle within the skin during the actuating.

2 . The method of claim 1 , wherein the inserting includes inserting the distal end portion of the needle into a subcutaneous tissue of the skin.

3 . The method of claim 1 , wherein:

the energy source includes a pressurized fluid; and

the actuating includes conveying the pressurized fluid to the medical injector such that the dermal filler is conveyed from the medical injector through the distal end portion of the needle.

4 . The method of claim 1 , further comprising:

regulating a flow rate of the dermal filler through the distal end portion of the needle during the actuating.

5 . The method of claim 1 , further comprising:

moving a valve body within a medicament flow path defined within the medical injector such that a flow rate of the dermal filler through the distal end portion of the needle is regulated.

6 . The method of claim 1 , further comprising:

regulating the energy source such that a flow rate of the dermal filler through the distal end portion of the needle is at least 0.02 cubic centimeters per minute.

7 . The method of claim 1 , wherein the actuating is performed at a first time after the inserting, the method further comprising:

regulating a flow rate of the dermal filler through the distal end portion of the needle at a first time after the moving such the flow rate of the dermal filler is substantially zero;

moving the distal end portion of the needle within the skin when the flow rate of the dermal filler is substantially zero; and

regulating a flow rate of the dermal filler through the distal end portion of the needle at a second time after the first time such the flow rate of the dermal filler is greater than zero.

8 . The method of claim 1 , wherein:

the inserting includes inserting the distal end portion of the needle into the skin in a distal direction; and

the moving includes moving the distal end portion of the needle in a proximal direction.

9 . The method of claim 1 , wherein:

the moving includes moving the needle from a first location within the skin to a second location within the skin, the first location spaced apart from the second location by at least 4 millimeters.

10 . The method of claim 1 , wherein the skin is any one of facial skin or skin of a neck region of the body.

11 . A method, comprising:

inserting a distal end portion of a needle of a medical injector into a skin of a body;

actuating a non-manually-powered machine operatively coupled to the medical injector such that a dermal filler is conveyed from the medical injector into the skin through the distal end portion of the needle; and

moving the distal end portion of the needle within the skin during the actuating.

12 . The method of claim 11 , wherein:

the non-manually-powered machine includes a pressurized fluid; and

the actuating includes conveying the pressurized fluid to the medical injector such that the dermal filler is conveyed from the medical injector through the distal end portion of the needle.

13 . The method of claim 11 , further comprising:

regulating a flow rate of the dermal filler through the distal end portion of the needle during the actuating.

14 . The method of claim 11 , further comprising:

moving a valve body within a medicament flow path defined within the medical injector such that a flow rate of the dermal filler through the distal end portion of the needle is regulated.

15 . The method of claim 11 , wherein:

the inserting includes inserting the distal end portion of the needle into the skin in a distal direction; and

the moving includes moving the distal end portion of the needle in a proximal direction.

16 . The method of claim 11 , wherein the skin is any one of facial skin or skin of a neck region of the body.

17 . The method of claim 11 , wherein

the actuating includes actuating the non-manually-powered machine such that at least 0.5 cubic centimeters of the dermal filler is conveyed from the medical injector into the skin through the distal end portion of the needle.

18 . An apparatus, comprising:

a medicament container having a piston movably disposed therein such that the medicament container is divided into a first portion and a second portion, the first portion configured to contain a medicament;

a needle coupled to the medicament container such that the needle is in fluid communication with the first portion of the medicament container;

an energy source operatively coupled to the piston, the energy source configured to produce a kinetic energy to move the piston within the medicament container such that the medicament having a viscosity of at least 1000 centipoise can be conveyed from the first portion of the medicament container through a distal end of the needle at a flow rate of at least 0.02 cubic centimeters per minute; and

a regulator configured to regulate the flow rate of the medicament through the distal end of the needle.

19 . The apparatus of claim 18 , wherein the regulator is configured to substantially stop the flow of the medicament and subsequently restart the flow of the medicament during an injection event.

20 . The apparatus of claim 18 , wherein:

the energy source includes a pressurized fluid, the energy source being configured to convey the pressurized fluid into the second portion of the medicament container; and

the regulator is configured to regulate at least one of a pressure of the pressurized fluid or a flow rate of the pressurized fluid into the second portion of the medicament container.

21 . The apparatus of claim 18 , wherein at least a portion of the regulator is disposed within a medicament delivery path, the medicament delivery path including at least the first portion of the medicament container and the needle.

22 . The apparatus of claim 18 , wherein the needle defines a lumen therethrough having a nominal inner diameter of less than approximately 0.191 millimeters.

23 . The apparatus of claim 18 , wherein the needle defines a lumen therethrough having a nominal inner diameter of less than approximately 0.140 millimeters.

24 . The apparatus of claim 18 , wherein the needle has a length of at least 17 millimeters and defines a lumen therethrough having a nominal inner diameter of less than approximately 0.191 millimeters.

25 . The apparatus of claim 18 , wherein the energy source includes a pressurized fluid configured to be conveyed to the second portion of the medicament container to move the piston within the medicament container, a pressure of the pressurized fluid within the second portion of the medicament container being greater than approximately 345 kilopascals.

26 . The apparatus of claim 18 , wherein the energy storage member includes a pressurized fluid configured to be conveyed to the second portion of the medicament container to move the piston within the medicament container, a pressure of the pressurized fluid within the second portion of the medicament container being greater than approximately 690 kilopascals.

27 . The apparatus of claim 18 , wherein the energy storage member includes a pressurized fluid configured to move the piston within the medicament container such that the medicament can be conveyed through the distal end of the needle at a flow rate of at least 0.5 cubic centimeters per minute.

28 . The apparatus of claim 18 , wherein the medicament has a viscosity of at least 10,000 centipoise.

29 . The apparatus of claim 18 , wherein the energy storage member includes a pressurized fluid configured to move the piston within the medicament container, the apparatus further comprising:

an adapter configured operatively couple the source of pressurized fluid to the piston such that a pressure of the medicament within the first portion of the medicament container is greater than a pressure of the pressurized fluid from the source of pressurized fluid.

30 . The apparatus of claim 18 , wherein the energy storage member includes a pressurized fluid configured to move the piston within the medicament container, the apparatus further comprising:

an adapter configured couple the source of pressurized fluid to the medicament container, the adapter including a coupling member configured to engage a flange of the medicament container in at least two circumferential locations.

31 . An apparatus, comprising:

a medical injector configured to contain a dermal filler, the medical injector including a needle defining a lumen therethrough having a nominal inner diameter of less than approximately 0.310 millimeters, the needle having a length of at least 17 millimeters;

a pressurized fluid source operatively coupled to the medical injector, a pressurized fluid from the pressurized fluid source having a pressure of at least 345 kilopascals, the pressurized fluid configured to actuate the medical injector such that the dermal filler can be conveyed from the medical injector through the lumen of the needle; and

a regulator configured to regulate the flow rate of the dermal filler through the lumen of the needle.

32 . The apparatus of claim 31 , wherein the regulator is configured to substantially stop the flow of the dermal filler and subsequently restart the flow of the dermal filler during an injection event.

33 . The apparatus of claim 31 , wherein the regulator is configured to regulate at least one of a pressure of the pressurized fluid or a flow rate of the pressurized fluid into the medical injector.

34 . The apparatus of claim 31 , wherein at least a portion of the regulator is disposed within a medicament delivery path.

35 . The apparatus of claim 31 , wherein at least a portion of the regulator is configured to obstruct a portion of a medicament delivery path.

36 . The apparatus of claim 31 , wherein the pressurized fluid has a pressure of at least 690 kilopascals.

37 . The apparatus of claim 31 , wherein the dermal filler has a viscosity of at least 1000 centipoise.

38 . The apparatus of claim 31 , further comprising:

an adapter configured couple the pressurized fluid source to the medical injector, the adapter including a coupling member configured to engage a flange of the medical injector in at least two circumferential locations.

39 . The apparatus of claim 31 , further comprising:

an adapter configured couple the pressurized fluid source to the medical injector, the adapter configured to amplify the pressure of the pressurized fluid such that a pressure of the medicament within the medical injector is greater than the pressure of the pressurized fluid from the pressurized fluid source,

the adapter including a coupling member configured to engage a flange of the medical injector, the coupling member configured to substantially surround the circumference of the flange of the medical injector.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Dec 22, 2010
From: SILICON VALLEY BANK
To: AESTHETIC SCIENCES CORPORATION
Reel/Frame 025604/0642 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 9, 2010
From: NORDSON EFD LLC
To: NORDSON CORPORATION
Reel/Frame 024959/0157 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 8, 2010
From: AESTHETIC SCIENCES CORPORATION
To: NORDSON EFD LLC
Reel/Frame 024950/0864 →
SECURITY AGREEMENT Recorded Apr 2, 2009
From: AESTHETIC SCIENCES CORPORATION
To: SILICON VALLEY BANK
Reel/Frame 022504/0987 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2008
From: SMITH, STACY R.
To: THERAPEUTICS, INC.
Reel/Frame 021396/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2008
From: THERAPEUTICS, INC.
To: AESTHETIC SCIENCES CORPORATION
Reel/Frame 021396/0572 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2008
From: HENEVELD, SCOTT; KRUMME, JOHN F.; WALTON, CHRISTIAN
To: AESTHETIC SCIENCES CORPORATION
Reel/Frame 021396/0580 →